Print

HVTN 502/Merck 023 (Step Study)

NCT00095576

Trial Details:

IIb Terminated
Merck, HIV Vaccine Trials Network (HVTN)
MRKAd5 HIV-1 gag/pol/nef
?Adults at High Risk of HIV-1 Infection
RandD/trials/Lists/ClinicalTrialsList
9/1/2009
Ad5 vectored with gag gene from the HIV-1 strain CAM-1, the pol gene from HIV-1 strain IIIB and the nef gene from HIV-1 strain JR-FL
?1.5x10^10 ad-vg/dose at Day 1, Week 4, and Week 26